Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2017 Filed Dec 12, 2017 18:03 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,067 | $27.18 | $273,604.95 |
DisclosureSEC source: 0001140361-17-045922 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,273 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.980 to $27.275, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 18:26 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,099 | $26.93 | $271,924.66 |
DisclosureSEC source: 0000899243-17-028497 · doc4.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,206 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.860 to $27.0150, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 18:21 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,047 | $27.33 | $274,535.28 |
DisclosureSEC source: 0000899243-17-028272 · doc4.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,107 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.1375 to $27.4950, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 07, 2017 Filed Dec 7, 2017 18:58 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,016 | $26.85 | $268,917.58 |
DisclosureSEC source: 0000899243-17-028196 · doc4.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,060 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.68 to $27.00, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 28, 2017 Filed Aug 28, 2017 17:14 UTC |
Barnes W. PageExecutive Vice President & CFO
|
GrantCommon Stock | 6,809 | $25.18 | $171,450.62 |
DisclosureSEC source: 0001140361-17-033418 · doc1.xml · nonDerivative · entry 1 Barnes W. Page · CIK 0001639109 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,249 F1 · shares: For 2017, the reporting person agreed to take 100% of his cash bonus in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take his bonus for 2017 in shares of restricted stock, the Company awarded the reporting person additional compensation, in restricted stock, equal to his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 28, 2017, which was $25.18. The number of securities issued is equal to the total cash bonus, including the additional compensation, divided by such price. Read SEC document |
| August 28, 2017 Filed Aug 28, 2017 17:15 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
GrantCommon Stock | 11,958 | $25.18 | $301,102.44 |
DisclosureSEC source: 0001140361-17-033421 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,044 F1 · shares: For 2017, the reporting person agreed to take 100% of his cash bonus in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take his bonus for 2017 in shares of restricted stock, the Company awarded the reporting person additional compensation, in restricted stock, equal to his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 28, 2017, which was $25.18. The number of securities issued is equal to the total cash bonus, including the additional compensation, divided by such price. Read SEC document |
| August 28, 2017 Filed Aug 28, 2017 21:11 UTC |
Stach Leigh AnnVP-Financial Reporting & CAO
|
GrantCommon Stock | 5,560 | $25.18 | $140,000.80 |
DisclosureSEC source: 0001140361-17-033415 · doc1.xml · nonDerivative · entry 1 Stach Leigh Ann · CIK 0001638477 · VP-Financial Reporting & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,172 F1 · shares: For 2017, the reporting person agreed to take 100% of her cash bonus in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take her bonus for 2017 in shares of restricted stock, the Company awarded the reporting person additional compensation, in restricted stock, equal to her cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 28, 2017, which was $25.18. The number of securities issued is equal to the total cash bonus, including the additional compensation, divided by such price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 17:18 UTC |
Barnes W. PageExecutive Vice President & CFO
|
GrantCommon Stock | 12,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-031169 · doc1.xml · nonDerivative · entry 1 Barnes W. Page · CIK 0001639109 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,440 Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 17:15 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
GrantCommon Stock | 21,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-031166 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,086 Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 21:10 UTC |
Stach Leigh AnnVP-Financial Reporting &CAO
|
GrantCommon Stock | 10,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-031162 · doc1.xml · nonDerivative · entry 1 Stach Leigh Ann · CIK 0001638477 · VP-Financial Reporting &CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,612 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 00:51 UTC |
LUMSDAINE ALFREDDirector
|
GrantCommon Stock | 2,015 | $25.81 | $52,007.15 |
DisclosureSEC source: 0001140361-17-025639 · doc1.xml · nonDerivative · entry 1 LUMSDAINE ALFRED · CIK 0001188873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,761 F1 · price: For 2017, the reporting person elected to take 100% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take his Board retainer for 2017 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $25.81. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 00:50 UTC |
Hensley Robert ZDirector
|
GrantCommon Stock | 1,550 | $25.81 | $40,005.50 |
DisclosureSEC source: 0001140361-17-025637 · doc1.xml · nonDerivative · entry 1 Hensley Robert Z · CIK 0001332086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,448 F1 · price: For 2017, the reporting person elected to take 71% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take a portion of his Board retainer for 2017 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the portion of the Board retainer taken in shares of restricted stock. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $25.81. The number of securities issued is equal to the total value of the portion of the Board retainer that the reporting person elected to take in restricted stock plus the value of the additional shares divided by such 10-day average stock price. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 00:55 UTC |
Van Horn R. LawrenceDirector
|
GrantCommon Stock | 2,015 | $25.81 | $52,007.15 |
DisclosureSEC source: 0001140361-17-025641 · doc1.xml · nonDerivative · entry 1 Van Horn R. Lawrence · CIK 0001641475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,569 F1 · price: For 2017, the reporting person elected to take 100% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take his Board retainer for 2017 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $25.81. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 00:48 UTC |
Gardner AlanDirector
|
GrantCommon Stock | 2,170 | $25.81 | $56,007.70 |
DisclosureSEC source: 0001140361-17-025635 · doc1.xml · nonDerivative · entry 1 Gardner Alan · CIK 0001638478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,776 F1 · price: For 2017, the reporting person elected to take 100% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take his Board retainer for 2017 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $25.81. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price. Read SEC document |
| May 30, 2017 Filed May 31, 2017 21:38 UTC |
Hensley Robert ZDirector
|
GrantCommon Stock | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023134 · doc1.xml · nonDerivative · entry 1 Hensley Robert Z · CIK 0001332086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,898 Read SEC document |
| May 30, 2017 Filed May 31, 2017 21:43 UTC |
LUMSDAINE ALFREDDirector
|
GrantCommon Stock | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023139 · doc1.xml · nonDerivative · entry 1 LUMSDAINE ALFRED · CIK 0001188873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,746 Read SEC document |
| May 30, 2017 Filed May 31, 2017 21:48 UTC |
Van Horn R. LawrenceDirector
|
GrantCommon Stock | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023141 · doc1.xml · nonDerivative · entry 1 Van Horn R. Lawrence · CIK 0001641475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,554 Read SEC document |
| May 30, 2017 Filed May 31, 2017 21:36 UTC |
Gardner AlanDirector
|
GrantCommon Stock | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023132 · doc1.xml · nonDerivative · entry 1 Gardner Alan · CIK 0001638478 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,606 Read SEC document |
| February 27, 2017 Filed Feb 27, 2017 21:54 UTC |
Hensley Robert ZDirector
|
PurchaseCommon Stock | 6,000 | $24.22 | $145,314.60 |
DisclosureSEC source: 0001140361-17-009437 · doc1.xml · nonDerivative · entry 1 Hensley Robert Z · CIK 0001332086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,858 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.16 to $24.2799, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 17:09 UTC |
Barnes W. PageExecutive Vice President & CFO
|
GrantCommon Stock | 18,596 | $23.05 | $428,637.80 |
DisclosureSEC source: 0001140361-17-002188 · doc1.xml · nonDerivative · entry 1 Barnes W. Page · CIK 0001639109 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,046 F1 · price: For 2017, the reporting person agreed to take 100% of his salary in the form of shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take his base salary for 2017 in these shares of restricted stock, the Company awarded Mr. Barnes additional compensation, in restricted stock, equal to his annual salary. The price of the securities acquired by the reporting person is based on the volume weighted average price of the Company's common stock for the 10 trading days immediately preceding January 13, 2017, which was $23.05. The number of securities issued is equal to the total salary, including the additional compensation, divided by such price. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 17:08 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
GrantCommon Stock | 32,651 | $23.05 | $752,605.55 |
DisclosureSEC source: 0001140361-17-002187 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,326 F1 · price: For 2017, the reporting person agreed to take 100% of his salary in the form of shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take his base salary for 2017 in these shares of restricted stock, the Company awarded Mr. Wallace additional compensation, in restricted stock, equal to his annual salary. The price of the securities acquired by the reporting person is based on the volume weighted average price of the Company's common stock for the 10 trading days immediately preceding January 13, 2017, which was $23.05. The number of securities issued is equal to the total salary, including the additional compensation, divided by such price. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 22:10 UTC |
Stach Leigh AnnVP-Financial Reporting & CAO
|
GrantCommon Stock | 15,183 | $23.05 | $349,968.15 |
DisclosureSEC source: 0001140361-17-002189 · doc1.xml · nonDerivative · entry 1 Stach Leigh Ann · CIK 0001638477 · VP-Financial Reporting & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,494 F1 · price: For 2017, the reporting person agreed to take 100% of her cash bonus in the form of shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take her base salary for 2017 in these shares of restricted stock, the Company awarded Ms. Stach additional compensation, in restricted stock, equal to her annual salary. The price of the securities acquired by the reporting person is based on the volume weighted average price of the Company's common stock for the 10 trading days immediately preceding January 13, 2017, which was $23.05. The number of securities issued is equal to the total salary, including the additional compensation, divided by such price. Read SEC document |
| November 22, 2016 Filed Nov 22, 2016 18:34 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,731 | $22.35 | $239,789.56 |
DisclosureSEC source: 0001140361-16-087645 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,675 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.20 to $22.425, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 21, 2016 Filed Nov 21, 2016 18:41 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,486 | $22.07 | $231,446.99 |
DisclosureSEC source: 0001140361-16-087466 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,944 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.98 to $22.30, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 18, 2016 Filed Nov 18, 2016 19:31 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 10,061 | $21.92 | $220,548.19 |
DisclosureSEC source: 0001140361-16-087312 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,458 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.73 to $22.07, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 17, 2016 Filed Nov 17, 2016 20:00 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 9,906 | $21.78 | $215,736.83 |
DisclosureSEC source: 0001140361-16-087141 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,397 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.37 to $22.28, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 16, 2016 Filed Nov 16, 2016 23:17 UTC |
LUMSDAINE ALFREDDirector
|
PurchaseCommon Stock | 522 | $20.89 | $10,904.58 |
DisclosureSEC source: 0001140361-16-086997 · doc1.xml · nonDerivative · entry 2 LUMSDAINE ALFRED · CIK 0001188873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,706 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.79 to $20.99, inclusive. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 23:17 UTC |
LUMSDAINE ALFREDDirector
|
PurchaseCommon Stock | 1,407 | $20.94 | $29,462.58 |
DisclosureSEC source: 0001140361-16-086997 · doc1.xml · nonDerivative · entry 1 LUMSDAINE ALFRED · CIK 0001188873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,184 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.92 to $20.99, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 07, 2016 Filed Oct 7, 2016 16:57 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 11,332 | $22.58 | $255,819.90 |
DisclosureSEC source: 0001140361-16-082306 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,491 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.09 to $22.70, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 06, 2016 Filed Oct 6, 2016 17:14 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 11,218 | $21.92 | $245,888.46 |
DisclosureSEC source: 0001140361-16-082181 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,159 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.34 to $22.23, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 18:18 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 11,120 | $21.44 | $238,443.94 |
DisclosureSEC source: 0001140361-16-082048 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,941 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.21 to $21.64, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 21, 2016 Filed Sep 21, 2016 17:47 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 13,401 | $21.97 | $294,454.81 |
DisclosureSEC source: 0001140361-16-080476 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,821 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.57 to $22.39, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 20, 2016 Filed Sep 20, 2016 17:52 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 13,088 | $21.66 | $283,527.96 |
DisclosureSEC source: 0001140361-16-080340 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,420 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.37 to $22.21, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 17:20 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 12,170 | $21.66 | $263,583.95 |
DisclosureSEC source: 0001140361-16-080209 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,332 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.24 to $21.985, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 19:45 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 9,906 | $21.16 | $209,598.08 |
DisclosureSEC source: 0001140361-16-080103 · doc1.xml · nonDerivative · entry 2 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,162 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.80 to $21.30, inclusive. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:45 UTC |
WALLACE TIMOTHY GDirector · Chairman, CEO and President
|
PurchaseCommon Stock | 9,616 | $21.44 | $206,204.54 |
DisclosureSEC source: 0001140361-16-080103 · doc1.xml · nonDerivative · entry 1 WALLACE TIMOTHY G · CIK 0001210485 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,256 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.32 to $21.53, inclusive. The reporting person undertakes to provide to Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.